Incomplete uptake of EGFR mutation testing and its impact on estimation of mutation prevalence in patients with non-squamous NSCLC: A population-based study in New Zealand.
Cancer Epidemiology(2018)
Abstract
•EGFR mutation testing is recommended for patients with non-squamous NSCLC.•Testing uptake is incomplete but has improved over time in New Zealand.•We proposed a method to quantify influences of patient factors on testing uptake.•The mutation prevalence could be lower than observed if all patients were tested.
MoreTranslated text
Key words
CI,EGFR,NHI,NSCLC,NZCR,NZDep,TKI
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined